Sabitlenmiş Tweet

ARUP is pleased to announce ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry, which will characterize small neoplastic populations with greater confidence and sensitivity, while minimizing specimen volume requirements. Learn more: bit.ly/4fLcdWo

English

















